Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 16/20 | 0.47 |
| ▸ | CTSS | P25774 | 7/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7433111 | 0.88 | CTSK (0.49) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7440796 | 0.85 | CTSK (0.64) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7443743 | 0.83 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7443442 | 0.82 | CTSK (0.43) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7445934 | 0.82 | CTSK (0.54) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7443568 | 0.80 | CTSK (0.42) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7444365 | 0.80 | CTSK (0.55) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL1515640 | 0.80 | CTSS (0.48) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL18614278 | 0.80 | CTSS (0.48) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL355405 | 0.80 | CTSS (0.48) | CTSKCTSSCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187905-B1 | PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES | HOFFMANN-LA ROCHE INC. | 2001-02-13 | — | — | US | disclosed |